Allarity Therapeutics, Inc.

NASDAQ (USD): Allarity Therapeutics, Inc. (ALLR)

Last Price

0.673

Today's Change

-0.007 (1.02%)

Day's Change

0.662 - 0.716

Trading Volume

2,673,445

Overview

Market Cap

1 Million

Shares Outstanding

2 Million

Avg Volume

3,278,970

Avg Price (50 Days)

3.77

Avg Price (200 Days)

13.04

PE Ratio

0.00

EPS

-205.20

Earnings Announcement

12-Aug-2024

Previous Close

0.68

Open

0.67

Day's Range

0.6622 - 0.7155

Year Range

0.643 - 283.2

Trading Volume

2,673,445

Price Change Highlight

1 Day Change

-1.07%

5 Day Change

-10.29%

1 Month Change

-55.15%

3 Month Change

-91.65%

6 Month Change

-93.53%

Ytd Change

-93.80%

1 Year Change

-99.76%

3 Year Change

-100.00%

5 Year Change

-100.00%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment